Drug intelligence / Profile preview

Naoluoxintong

Development stage
Unknown
Lead developer
First Affiliated Hospital of Anhui University of Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Naoluoxintong is a Traditional Chinese Medicine (TCM) formulation, typically administered as a granule, developed by the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine. It is primarily indicated for the treatment of ischemic stroke during the recovery period, specifically for patients presenting with the TCM syndrome of Qi deficiency and blood stasis. The formulation is designed to tonify Qi, activate blood circulation, and resolve stasis. Clinical studies, including a registered Phase 4 trial (ChiCTR-IPR-14005269), have evaluated its efficacy and safety when used in combination with standard antiplatelet therapy, such as aspirin, to improve neurological function and clinical outcomes in stroke patients.

Other names
Naoluoxintong granuleNaoluoxintong keli

Beyond the preview

Go deeper on Naoluoxintong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naoluoxintong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call